Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients.
about
Neuropeptides in depression: role of VGFBipolar Disorder: Role of Inflammation and the Development of Disease BiomarkersPsychosis and autism as diametrical disorders of the social brainA longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophreniaIntake of 7,8-Dihydroxyflavone During Juvenile and Adolescent Stages Prevents Onset of Psychosis in Adult Offspring After Maternal Immune ActivationIn SilicoModel-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology.Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.The role of BDNF as a mediator of neuroplasticity in bipolar disorder.The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis.Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis.The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis.New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases.Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.Myelin, copper, and the cuprizone model of schizophreniaBrain-derived neurotrophic factor levels in first episode of psychosis: A systematic review.Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndromePeripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies.Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation.BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.Association Between MKP-1, BDNF, and Gonadal Hormones with Depression on Perimenopausal Women.BDNF-TrkB signaling and neuroprotection in schizophreniaNeurobiological trait abnormalities in bipolar disorder.Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function.Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women.Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis.Systematically characterizing dysfunctional long intergenic non-coding RNAs in multiple brain regions of major psychosis.The role of BDNF in depression on the basis of its location in the neural circuitry.Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis.Therapeutic use of omega-3 fatty acids in bipolar disorder.D-serine and schizophrenia: an update.The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder.The search for peripheral disease markers in psychiatry by genomic and proteomic approaches.Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis.Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory.Transcriptional Regulation of Brain-derived Neurotrophic Factor Coding Exon IX: ROLE OF NUCLEAR RESPIRATORY FACTOR 2.Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
P2860
Q24647788-F759BDBA-63DF-457C-87F1-BDA6ED88DD05Q26772017-F71670D4-77AF-4167-BE7A-EC1272B520D2Q28285118-AF620964-63E6-4E01-9390-3BE3B39D3D00Q28539784-72C3EC7F-FA95-4D22-A951-30E8806FEC97Q30370073-F2D140B1-F169-4544-874F-F7655D5D135DQ33662831-2D2E000F-3F0E-4B9A-B830-75ACEB9FE5A4Q34132832-33622D9E-B1D8-448A-A32B-CB52032F58CAQ34497541-6C078540-1575-4C16-B356-7753D50E2B83Q34540937-F5E99B71-FE5D-4122-8FCF-55F78111881BQ34548501-78FA075A-A9D8-41EC-A857-57A1F3522F9DQ34556534-55930437-7262-469E-989D-822E784C020BQ34567939-89D13AAA-0BC5-45BE-99E1-FFA32ACB1097Q34621808-E07B31E7-6060-4A6F-88DE-A50224C6C108Q34680959-306E659F-353F-457B-853B-547065C66595Q35205829-47EB005B-2068-4A64-83F4-038549422E0BQ35284133-6F436EBE-82FA-4E94-9C63-BACF451906FCQ35856498-35868106-0834-44DB-ABF5-B84A6849A3F7Q36113520-CC225343-0A5B-4C5B-930C-8DF5FC1657EFQ36377832-6067FFB4-6EBB-42AD-BF18-023027D64206Q36543414-59F71954-841B-489C-80BF-6CB3A1010DE3Q36589545-6106C9D8-9731-4403-8D6D-CC7F68787393Q37489488-445DC839-A1A0-4ACD-85FE-11D6D8CB2651Q37588877-40B9380B-82C8-4269-959F-0BBFFA11EC4BQ37613308-ED655DF1-C805-4689-87EE-35A27E04BAD8Q37615022-CAFEB62D-9BB5-49A2-9612-72F00AA357A8Q37687577-CFFE136B-ECCF-45AB-A7CD-081EB9021D66Q37729843-1E192F0F-74D0-4301-BCE6-1833408E7B05Q37825989-1B7AF5F5-B25E-476E-8A8D-E01E9401A9D5Q37896631-4CD7FC4D-BBA0-4EF4-ADC5-3B740E99F5A0Q38031285-91591805-8B08-4890-ADF8-C9C73CECBD44Q38031289-14C67918-84F1-4534-89A7-37BBDAE1467DQ38089247-CCDD99DC-EF5C-4852-ACAC-94C688E88929Q38209971-D78EAA5F-8916-4E11-8E4A-40C0F08C9353Q38550939-524EF0B8-2BCD-4605-85B2-07CBCA1A858EQ38760788-B74C0D02-3162-423E-9595-25ACCA50033DQ38819864-F3A3B60E-1BE3-48C6-8C18-50B7C8445DECQ42157677-E52F3794-36DC-4034-8DBC-0D989D26BEBEQ42380612-4648C36C-726B-4909-A752-6A603C740A00Q42614417-8BC14B80-930E-4FFC-B227-FDD5ED80AF56Q46238863-08F9B861-510D-4431-88B6-506A655B5BE5
P2860
Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Decreased levels of plasma BDN ...... and bipolar disorder patients.
@en
Decreased levels of plasma BDN ...... and bipolar disorder patients.
@nl
type
label
Decreased levels of plasma BDN ...... and bipolar disorder patients.
@en
Decreased levels of plasma BDN ...... and bipolar disorder patients.
@nl
prefLabel
Decreased levels of plasma BDN ...... and bipolar disorder patients.
@en
Decreased levels of plasma BDN ...... and bipolar disorder patients.
@nl
P2093
P921
P1476
Decreased levels of plasma BDN ...... and bipolar disorder patients
@en
P2093
Aitor Palomino
Ana Aldama
Ana González-Pinto
Cristina González-Gómez
Fernando Mosquera
Gixane González-García
P304
P356
10.1016/J.SCHRES.2006.05.028
P407
P577
2006-07-10T00:00:00Z